AU2021902406A0 - Self-adjuvanting VLP and uses thereof - Google Patents

Self-adjuvanting VLP and uses thereof

Info

Publication number
AU2021902406A0
AU2021902406A0 AU2021902406A AU2021902406A AU2021902406A0 AU 2021902406 A0 AU2021902406 A0 AU 2021902406A0 AU 2021902406 A AU2021902406 A AU 2021902406A AU 2021902406 A AU2021902406 A AU 2021902406A AU 2021902406 A0 AU2021902406 A0 AU 2021902406A0
Authority
AU
Australia
Prior art keywords
adjuvanting
vlp
self
adjuvanting vlp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2021902406A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Melbourne
Original Assignee
University of Melbourne
Filing date
Publication date
Application filed by University of Melbourne filed Critical University of Melbourne
Publication of AU2021902406A0 publication Critical patent/AU2021902406A0/en
Abandoned legal-status Critical Current

Links

AU2021902406A 2021-08-04 Self-adjuvanting VLP and uses thereof Abandoned AU2021902406A0 (en)

Publications (1)

Publication Number Publication Date
AU2021902406A0 true AU2021902406A0 (en) 2021-08-19

Family

ID=

Similar Documents

Publication Publication Date Title
EP4105211A4 (en) Pyrimidoheterocyclic compounds and application thereof
EP3913001A4 (en) Anti-cld18a2 nanobody and application thereof
EP3917934A4 (en) Compounds and uses thereof
EP3917526A4 (en) Compounds and uses thereof
EP3980437A4 (en) Una amidites and uses thereof
EP3917529A4 (en) Compounds and uses thereof
EP3917517A4 (en) Compounds and uses thereof
EP3959307A4 (en) Engineered cells and uses thereof
EP4037670A4 (en) 5-fluoronicotinamide derivatives and uses thereof
EP3917527A4 (en) Compounds and uses thereof
EP3990028A4 (en) Micellar nanoparticles and uses thereof
EP4021928A4 (en) Modified n-810 and methods therefor
EP4034548A4 (en) Coronavirus vaccines and uses thereof
EP3941908A4 (en) Compounds and uses thereof
EP4034535A4 (en) Aza-quinoline compounds and uses thereof
EP4063382A4 (en) Pif1-like helicase and application thereof
EP3911322A4 (en) Compounds and uses thereof
EP3914593A4 (en) Compounds and uses thereof
EP3947365A4 (en) Substituted-n-heteroaryl compounds and uses thereof
AU2021902406A0 (en) Self-adjuvanting VLP and uses thereof
AU2023901437A0 (en) Self-adjuvanting VLP and uses thereof
EP4028024A4 (en) Engineered cells and uses thereof
AU2021233058B2 (en) Pyrimidoheterocyclic compounds and application thereof
AU2020904717A0 (en) Methods and Compositions-II
AU2022381992A1 (en) Lurbinectedin and atezolizumab combinations